Advanced Filters
noise
Found 1,651 clinical trials
S Soo Lim, MD, PHD

Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis

The current study aimed to thoroughly compare a thiazolidinedione and an sodium-glucose cotransporter-2 (SGLT2) inhibitor regarding various clinical issues including atherosclerosis. Enavogliflozin is compared to Pioglitazone in the glucose-lowering effects of adding to the treatment of patients with type 2 diabetes whose HbA1c levels are not controlled by Metformin with …

20 - 80 years of age All Phase 4
B Berna DINCER, PhD

The Effect of Emotional Freedom Technique on Psychological Health and Well-being in People With Type 2 Diabetes.

Type 2 diabetes is a major meatbolic condition. People living with Type 2 diabetes come across a wide range of health issues, including psychological health. Specifically, diabetes distress are in high levels among them. Diabetes distress is associated with psychological states such as anxiety, lower levels of self-care, and higher …

18 years of age All Phase N/A
A Aurora Merovci, MD

SGLT2i, Pioglitazone, and Ketone Production in T2D

To examine whether the empagliflozin-induced stimulation of EGP, lipolysis, and ketone production in T2D individuals can be blocked by pioglitazone (which has direct hepatic and adipose tissue effects).

30 - 75 years of age All Phase 1

A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

This trial is conducted in Indonesia. The aim of the trial is to evaluate the efficacy and safety of BGM0504 versus semaglutide as add-on to metformin in patients with type 2 diabetes

18 - 75 years of age All Phase 3

Personalized Nutrition for Type 2 Diabetes

This project will compare medical nutrition therapy personalized by continuous glucose monitor (CGM) feedback to control interventions in participants with type 2 diabetes mellitus (T2DM).

18 years of age All Phase N/A
K Katherine D Vickery, MD

Effectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management

The goal of this clinical trial is to learn if the Diabetes Homelessness Medication Support (D-HOMES) wellness coaching model is effective for adults who speak English or Spanish, have Type 2 diabetes with an HbA1c at or above 7.5, and have recently experienced homelessness. Researchers will compare a one-time education …

18 years of age All Phase N/A
X Xia Li, MD/PHD

Hybrid Closed-Loop for Perioperative Glycemic Control in T2DM With Parenteral Nutrition

Glycemic control in surgical patients with type 2 diabetes mellitus (T2DM) receiving parenteral nutrition represents a major clinical challenge. This randomized controlled trial evaluates the comparative effectiveness and safety of hybrid closed-loop (HCL) insulin delivery versus conventional insulin pumps combined with continuous glucose monitoring (CGM) in perioperative T2DM patients requiring …

18 years of age All Phase N/A
J Joshua Lam, MBBS

Cohort Study Evaluating Glycaemic Control in Individuals with Type 2 Diabetes Mellitus Through Digital Therapeutics (DM DTx)

This study is conducted to evaluate the effectiveness of Digital therapeutics (DTx) in managing patients with Type 2 Diabetes Mellitus (T2DM) by delivering digital lifestyle interventions through a national health application (BruHealth).

18 - 70 years of age All Phase N/A
N Natalia Garban

Type 2 Continuous Glucose Monitoring Academy

The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D): The first aim is to determine how feasible it is to adapt the Continuous Glucose Monitoring Academy curriculum to …

8 - 21 years of age All Phase N/A
C CDRC Manager

THC Effects on Glucose in Type 2 Diabetes

This study will examine the effects THC has on Glucose Metabolism and Endothelial Functioning in participants with Type 2 Diabetes. The participants will complete blood tests and tests to measure energy expenditure, CVD risks, and glucose metabolism. These tests will be performed prior to start of treatment and again after …

21 - 70 years of age All Phase 1

Simplify language using AI